Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Bean

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
American Clinical Laboratory|September 13, 2002
A brief update on chemokines, chemokine receptors, and HIVPamela Bean
American Clinical Laboratory|September 13, 2002
HDL, alcohol, and health: from the benefits of moderation to the hazards of abusePamela Bean
American Clinical Laboratory|June 29, 2002
Evolving toxicities associated with anti-HIV therapiesPamela Bean
American Clinical Laboratory|July 19, 2002
Latest discoveries on the infection and coinfection with hepatitis D virusPamela Bean
American Clinical Laboratory|October 17, 2002
New global initiatives to improve the interpretation of drug resistance testing for HIV-1Pamela Bean
American Clinical Laboratory|June 1, 2002
New strategies in the treatment of hepatitis CPamela Bean
American Clinical Laboratory|November 21, 2002
HIV genetic mutations causing resistance to the new drug T-20: recent findingsPamela Bean
American Clinical Laboratory|June 29, 2002
The use of alternative medicine in the treatment of hepatitis CPamela Bean
American Clinical Laboratory|July 19, 2002
Containing the spread of HIV infection among high-risk groupsPamela Bean
American Clinical Laboratory|September 13, 2002
A case study in hepatitis C disease progression: reaching out while searching for new cluesPamela Bean
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
American Clinical Laboratory|September 13, 2002
A brief update on chemokines, chemokine receptors, and HIVPamela Bean
American Clinical Laboratory|September 13, 2002
HDL, alcohol, and health: from the benefits of moderation to the hazards of abusePamela Bean
American Clinical Laboratory|June 29, 2002
Evolving toxicities associated with anti-HIV therapiesPamela Bean
American Clinical Laboratory|July 19, 2002
Latest discoveries on the infection and coinfection with hepatitis D virusPamela Bean
American Clinical Laboratory|October 17, 2002
New global initiatives to improve the interpretation of drug resistance testing for HIV-1Pamela Bean
American Clinical Laboratory|June 1, 2002
New strategies in the treatment of hepatitis CPamela Bean
American Clinical Laboratory|November 21, 2002
HIV genetic mutations causing resistance to the new drug T-20: recent findingsPamela Bean
American Clinical Laboratory|June 29, 2002
The use of alternative medicine in the treatment of hepatitis CPamela Bean
American Clinical Laboratory|July 19, 2002
Containing the spread of HIV infection among high-risk groupsPamela Bean
American Clinical Laboratory|September 13, 2002
A case study in hepatitis C disease progression: reaching out while searching for new cluesPamela Bean
Pageof 4